MELANOMA STAGE II
Clinical trials for MELANOMA STAGE II explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE II trials appear
Sign up with your email to follow new studies for MELANOMA STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New keytruda copycat tested in melanoma trial
Disease control OngoingThis study tests whether FYB206, a biosimilar (or copycat) of the cancer drug Keytruda, works similarly in the body. It involves 96 people with stage IIB/IIC or III melanoma that was completely removed by surgery. Participants receive either FYB206 or Keytruda, and researchers co…
Matched conditions: MELANOMA STAGE II
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated Jun 26, 2026 14:08 UTC
-
Melanoma survivors: new study tracks immunotherapy side effects
Knowledge-focused OngoingThis study follows 126 melanoma survivors who are receiving immunotherapy after surgery. Researchers will track side effects and quality of life for up to 24 months. They will also collect blood samples to look for markers that might predict who gets side effects. The goal is to …
Matched conditions: MELANOMA STAGE II
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC